Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma

BACKGROUND: We previously reported early on-treatment significant modulation in circulating regulatory T cell (Treg), myeloid derived suppressor cells (MDSC) and antigen-specific type I CD4+ and CD8+ T cells that correlated with clinical outcome in regionally advanced melanoma patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Retseck, Janet, Nasr, Alexis, Lin, Yan, Lin, Huang, Mendiratta, Prateek, Butterfield, Lisa H., Tarhini, Ahmad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033230/
https://www.ncbi.nlm.nih.gov/pubmed/29973204
http://dx.doi.org/10.1186/s12967-018-1563-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033230/
https://www.ncbi.nlm.nih.gov/pubmed/29973204
http://dx.doi.org/10.1186/s12967-018-1563-y

Ejemplares similares